Methods for treating vascular disorders

Details for Australian Patent Application No. 2005204375 (hide)

Owner Allergan, Inc.

Inventors Brin, Mitchell F.; Naumann, Markus K.

Agent Davies Collison Cave

Pub. Number AU-B-2005204375

PCT Pub. Number WO2005/067961

Priority 10/754,364 08.01.04 US

Filing date 7 January 2005

Wipo publication date 28 July 2005

Acceptance publication date 26 August 2010

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/067961 Priority application(s): WO2005/067961

26 August 2010 Application Accepted

  Published as AU-B-2005204375

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005204378-A method of reducing serum proinsulin levels in type 2 diabetics

2005204372-Child resistant visible blister end cap